Key statistics
On Friday, Pharming Group NV (PHG:MUN) closed at 7.50, 6.38% above its 52-week low of 7.05, set on Sep 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.50 |
---|---|
High | 7.50 |
Low | 7.50 |
Bid | 7.85 |
Offer | 8.65 |
Previous close | 7.45 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 18 2024 07:05 BST.
More ▼
Announcements
- Pharming Group to report third quarter 2024 financial results on October 24
- Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
- Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
- Pharming Group to participate in September investor conferences
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports second quarter and first half 2024 financial results and provides business update
- Pharming Group to report second quarter and first half 2024 financial results on August 1
- Pharming Group to participate in June investor conferences
- Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
- Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
More ▼